Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://andrewtuyx646659.myparisblog.com/36855558/retatrutide-a-promising-new-treatment-for-obesity